A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Feb. 6, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP has released its Feb. 5 Customs Bulletin (Vol. 59, No. 6), which includes the following ruling actions:
Even as President Donald Trump talked about his intention to announce tariff changes next week, he expressed confidence that Japan might be spared, because of their promises to buy more American exports.
President Donald Trump, speaking to reporters during a Feb. 7 press conference with Japan's Prime Minister, said that he would probably announce, either Monday or Tuesday, Feb. 10 or Feb. 11, "reciprocal tariffs where a country pays so much or charges us so much and we do the same, so very reciprocal because I think that's the only fair way to do it, that way nobody's hurt. They charge us, we charge them."
The reversal of an order banning Chinese products from de minimis startled importers and members of the Senate Finance Committee, who were puzzling about how long it would be until the policy flipped again, and why the Commerce Department, which has never had involvement in de minimis before, has been put in charge of deciding when to implement the order.
Duty-free de minimis treatment is available for Chinese-origin goods again, but only until "notification by the Secretary of Commerce to the President that adequate systems are in place to fully and expediently process and collect tariff revenue for all Chinese products," the White House said in an amendment to its Feb. 1 executive order on China tariffs.
The European Commission is considering exempting more than 80% of companies that otherwise would be subject to import tariffs under the bloc’s upcoming Carbon Border Adjustment Mechanism, Climate Commissioner Wopke Hoekstra said this week. Hoekstra said the EU has found that the law may disproportionately target companies that aren’t responsible for most carbon emissions.
The International Trade Commission published notices in the Feb. 6 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission is issuing a limited exclusion order banning imports of medical admixture devices (ITC Inv. No. 337-TA-1362) from U.S. company Summit International Medical Technologies, Advcare Medical of Taiwan, and Dragon Heart of China, it said in a notice to be published Feb. 7. Additionally, the ITC issued cease and desist orders against Summit International but imposed no bond for covered articles imported or sold during the period of presidential review. The order concludes a Section 337 investigation the ITC launched in May 2023, based on allegations by West Pharmaceutical Services of Pennsylvania and West Pharma of Israel that the respondents are importing fluid transfer devices that have a trifurcated connector body with an integral vial adapter (see 2305100005) that copy and infringe its patented designs.
The Commerce Department published notices in the Federal Register Feb. 6 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):